Disposable Bioreactors Based on Wave Agitation Technology - Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes. - BioPharm

ADVERTISEMENT

Disposable Bioreactors Based on Wave Agitation Technology
Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes.


BioPharm International


DIANA MARJANOVIC is a product manager of disposable bioreactors at Sartorius AG, Switzerland. Gerhard Greller is a scientist in process development, biotechnology, at Sartorius AG, Germany.

References

1. L. Stryer L. Biochemistry, 4th ed. New York (NY): W.H. Freeman and Company; 1995.

2. Wurm F. Nature Biotech 2004;22: 13–98.

3. Sandig V. et al. Mammalian cells. In: Gelissen G., editor. Production of recombinant proteins. (Wiley-VCH; 2005)

4. Weber W. et al. Catching the Wave: The BEVS and the Biowave. Novartis Pharma Research, Switzerland.

5. Eibl D. and Eibl R. BioWorld 2005; 3:1–2 (Supplement BioteCHnet)

6. Pierce, Bioprocessing J 2004; 3: 51–56.

7. Ling et al., Biotechnol Prog 2003; 19(1), 158–62

8. Weber W. et al. Cytotechn 2002; 38: 77–85.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here